Structured management strategy based on the Gastro-oesophageal Reflux Disease (GERD) Questionnaire (GerdQ) vs. usual primary care for GERD: Pooled analysis of five cluster-randomised European studies

International Journal of Clinical Practice

Volumn 66, Issue 9, 2012, Pages 897-905

  Ponce, J ^a   Garrigues, V ^a   Agreus L ^b   Tabaglio, E ^c   Gschwantler, M ^d   Guallar, E ^e   Tafalla, M ^f   Nuevo, J ^f   Hatlebakk, J ^g  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b Center for Family and Community Medicine   (Sweden)

^c Societ Italiana Medicina Generale   (Italy)

^d WILHELMINEN HOSPITAL   (Austria)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^f ASTRAZENECA   (United Kingdom)

^g HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ESOMEPRAZOLE; GENERIC DRUG; NON PRESCRIPTION DRUG; PROTON PUMP INHIBITOR;

ADULT; ARTICLE; CLINICAL EFFECTIVENESS; CLUSTER ANALYSIS; CONTROLLED STUDY; EUROPE; FEMALE; FOLLOW UP; GASTRO OESOPHAGEAL REFLUX QUESTIONNAIRE; GASTROESOPHAGEAL REFLUX; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT CARE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STRUCTURED MANAGEMENT APPROACH; SYMPTOM; TREATMENT INDICATION;

CLUSTER ANALYSIS; CRITICAL PATHWAYS; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84865260649     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2012.02992.x     Document Type: Article

References (31)

1. Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006; 101: 1900-20.
2. Dent J, El-Serag HB, Wallander MA, Johansson S,. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005; 54: 710-7. (Pubitemid 40559260)
3. Ronkainen J, Aro P, Storskrubb T, et al. Gastro-oesophageal reflux symptoms and health-related quality of life in the adult general population-the Kalixanda study. Aliment Pharmacol Ther 2006; 23: 1725-33. (Pubitemid 43846416)
4. Gisbert JP, Cooper A, Karagiannis D, et al. Impact of gastroesophageal reflux disease on patients' daily lives: a European observational study in the primary care setting. Health Qual Life Outcomes 2009; 7: 60.
5. Toghanian S, Wahlqvist P, Johnson DA, et al. The burden of disrupting gastro-oesophageal reflux disease: a database study in US and European cohorts. Clin Drug Investig 2010; 30: 167-78.
6. Gisbert JP, Cooper A, Karagiannis D, et al. Impact of gastroesophageal reflux disease on work absenteeism, presenteeism and productivity in daily life: a European observational study. Health Qual Life Outcomes 2009; 7: 90.
7. Jones R, Liker HR, Ducrotté P,. Relationship between symptoms, subjective well-being and medication use in gastro-oesophageal reflux disease. Int J Clin Pract 2007; 61: 1301-7. (Pubitemid 47052376)
8. Hungin AP, Hill C, Raghunath A,. Systematic review: frequency and reasons for consultation for gastro-oesophageal reflux disease and dyspepsia. Aliment Pharmacol Ther 2009; 30: 331-42.
9. Liker HR, Ducrotté P, Malfertheiner P,. Unmet medical needs among patients with gastroesophageal reflux disease: a foundation for improving management in primary care. Dig Dis 2009; 27: 62-7.
10. Fass R, Shapiro M, Dekel R, Sewell J,. Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease-where next? Aliment Pharmacol Ther 2005; 22: 79-94. (Pubitemid 41039696)
11. Gisbert JP, Cooper A, Karagiannis D, et al. Management of gastro-oesophageal reflux disease in primary care: a European observational study. Curr Med Res Opin 2009; 25: 2777-84.
12. Baldi F, Crotta S, Penagini R,. Guidelines for the diagnostic and therapeutic management of patients with gastro-oesophageal reflux disease. A position statement of The Italian Association of Hospital Gastroenterologists (AIGO), Italian Society of Gastrointestinal Endoscopy (SIED), and Italian Society of Gastroenterology (SIGE). Ital J Gastroenterol Hepatol 1998; 30: 107-12. (Pubitemid 28220712)
13. Katelaris P, Holloway R, Talley N, et al. Gastro-oesophageal reflux disease in adults: guidelines for clinicians. J Gastroenterol Hepatol 2002; 17: 825-33.
14. Moraes-Filho J, Cecconello I, Gama-Rodrigues J, et al. Brazilian consensus on gastroesophageal reflux disease: proposals for assessment, classification, and management. Am J Gastroenterol 2002; 97: 241-8. (Pubitemid 34160745)
15. Armstrong D, Marshall JK, Chiba N, et al. Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults-update 2004. Can J Gastroenterol 2005; 19: 15-35. (Pubitemid 40305635)
16. Koop H, Schepp W, Muller-Lissner S, et al. Consensus conference of the DGVS on gastroesophageal reflux [in German]. Z Gastroenterol 2005; 43: 163-4. (Pubitemid 40332908)
17. Marzo M, Carrillo R, Mascort JJ, et al. Management of patients with GERD. Clinical practice guideline. 2008 update. Clinical Practice Guideline Working Group on GERD [in Spanish]. Gastroenterol Hepatol 2009; 32: 431-64.
18. Davis DA, Taylor-Vaisey A,. Translating guidelines into practice. A systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines. Can Med Assoc J 1997; 157: 408-16. (Pubitemid 27384745)
19. James PA, Cowan TM, Graham RP, Majeroni BA,. Family physicians' attitudes about and use of clinical practice guidelines. J Fam Pract 1997; 45: 341-7.
20. Grol R,. Successes and failures in the implementation of evidence-based guidelines for clinical practice. Med Care 2001; 39: II46-54. (Pubitemid 33752650)
21. Wright J, Warren E, Reeves J, et al. Effectiveness of multifaceted implementation of guidelines in primary care. J Health Serv Res Policy 2003; 8: 142-8. (Pubitemid 36850990)
22. Grimshaw JM, Thomas RE, MacLennan G, et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess 2004; 8: iii-iv, 1-72.
23. Ponce J, Garrigues V, Agréus L, et al. Structured management strategy versus usual care for gastroesophageal reflux disease: rationale for pooled analysis of five European cluster-randomized trials. Therap Adv Gastroenterol 2011; 4: 11-26.
24. Jones R, Junghard O, Dent J, et al. Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care. Aliment Pharmacol Ther 2009; 30: 1030-8.
25. Jones R, Coyne K, Wiklund I,. The gastro-oesophageal reflux disease impact scale: a patient management tool for primary care. Aliment Pharmacol Ther 2007; 25: 1451-9. (Pubitemid 46848895)
26. Revicki DA, Wood M, Wiklund I, Crawley J,. Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease. Qual Life Res 1998; 7: 75-83. (Pubitemid 28113967)
27. Shaw M, Dent J, Beebe T, et al. The Reflux Disease Questionnaire: a measure for assessment of treatment response in clinical trials. Health Qual Life Outcomes 2008; 6: 31.
28. Dean BB, Gano ADJ, Knight K, et al. Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin Gastroenterol Hepatol 2004; 2: 656-64. (Pubitemid 39013424)
29. Fass R,. Functional heartburn: what it is and how to treat it. Gastrointest Endosc Clin N Am 2009; 19: 23-33.
30. Fass R, Sifrim D,. Management of heartburn not responding to proton pump inhibitors. Gut 2009; 58: 295-309.
31. Mearin F, Ponce J, Ponce M, et al. Frequency and clinical implications of supraesophageal and dyspeptic symptoms in gastroesophageal reflux disease. Eur J Gastroenterol Hepatol 2012; 24: 665-74.